Abstract:Objective To assess the expression of histone modifications in tumor cells of the patients with TNM stage I-III colorectal cancer (CRC) and its clinical outcome and association with age at surgery. Methods To quantify expression, immunohistochemical staining of the histone modifications was performed on a tissue microarray containing colorectal tissues of the 254 patients with TNM stage I-III CRC. The patients were stratified according to survival status and age-related tumor expression patterns of both H3K9ac and H3K27me3 were compared. Results Decreased expression with advancing age was observed in the patients who were alive after follow-up (no-event group), whereas increased expression with advancing age was observed in the patients who presented with a recurrence or death during follow-up (event group). These opposite expression patterns translated into age-dependent prognostic value of the individual histone modifications and their combination in CRC. The prognostic value reversed with increasing age, high nuclear expression associated with good clinical outcome in the young adults, in contrast, with poor clinical outcome in the elderly patients. Conclusions We identified an age-dependent prognostic effect of nuclear expressions of histone modifications H3K9ac and H3K27me3 and their combination in patients with CRC. We have demonstrated for the first time the prognostic impact of an epigenetic marker can not only change but also reverse with increasing age. This observation supports the hypothesis that CRC biology is distinct between young adults and the elderly and emphasizes the importance of focusing on age-related effects in CRC.